delphistem

📍 Atlanta, United States👥 4 employees💰 Last funded Sep 2025
Biotechnology Research🌐 delphistem.com
Website LinkedIn
Delphistem is a biotech company pioneering a stem-cell based treatment to cure diabetes by reprogramming a patients own cells into insulin-producing pancreatic cells. Our mission is to eliminate diseases caused by biological aging, starting with diabetes. We also offer stem cell (iPSC) storage services, enabling individuals to preserve their healthiest cells today for personalized treatments tomorrow. Our non-invasive collection process and accessible membership plans make proactive health management a reality. Learn more at www.delphistem.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Albania
1
Frequently asked questions
Who invested in delphistem?
delphistem has 1 investors on record on gritt.io.
When did delphistem last raise funding?
The most recent investment in delphistem recorded on gritt.io was in September 2025.
What industry is delphistem in?
delphistem operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is delphistem based?
delphistem is headquartered in Atlanta, United States.